Product image of Metformin Accord (Metformin) supplied by GNH India

Metformin Accord

Active Ingredient:
Metformin
Origin:
EU

Metformin Accord (Metformin)

Metformin, the active ingredient in Metformin Accord, is a Biguanide presented as an oral tablet for oral use. It lowers elevated blood glucose levels and is indicated for the management of type 2 diabetes mellitus in adult patients. It improves peripheral insulin sensitivity and reduces hepatic glucose production, helping to achieve glycaemic control.

GNH India supplies Metformin Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides regulatory documentation to support import and distribution across multiple regions.

Manufacturer / TM Owner

Accord Healthcare B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metformin is used primarily in the management of disorders related to impaired glucose regulation.

  • Type 2 diabetes mellitus: improves glycaemic control by lowering fasting and post‑prandial blood glucose.
  • Prediabetes: delays progression to overt diabetes by enhancing insulin sensitivity.
  • Polycystic ovary syndrome (off‑label): may improve ovulatory function and reduce androgen levels.

How It Works

  • Metformin exerts its antihyperglycaemic effect by inhibiting hepatic gluconeogenesis, decreasing intestinal glucose absorption, and enhancing peripheral glucose uptake in muscle and adipose tissue. The drug activates AMP‑activated protein kinase (AMPK), which modulates metabolic pathways and improves insulin sensitivity without directly stimulating insulin secretion. It also reduces mitochondrial respiration, leading to a mild increase in cellular AMP levels that further stimulates AMPK activity.

Side Effects

Metformin may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Gastrointestinal upset: nausea, abdominal discomfort, and loss of appetite.
  • Diarrhea: frequent loose stools, especially during treatment initiation.
  • Metallic taste: transient alteration in taste perception.
  • Flatulence: increased intestinal gas.
  • Weight loss: modest reduction in body weight.

Serious or Rare Side Effects

  • Lactic acidosis: life‑threatening accumulation of lactate, particularly in renal impairment.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Hepatic failure: marked elevation of liver enzymes and liver dysfunction.
  • Vitamin B12 deficiency: long‑term use may reduce absorption leading to anemia.
  • Hypoglycaemia: rare when combined with other glucose‑lowering agents.

Precautions & Warnings

Before initiating Metformin, several safety considerations should be evaluated to minimise risk.

  • Renal function: assess creatinine clearance and avoid use in severe renal impairment.
  • Hepatic disease: contraindicated in patients with significant liver dysfunction.
  • Alcohol consumption: limit intake to reduce risk of lactic acidosis.
  • Cardiovascular surgery: withhold Metformin 48 hours before and after procedures involving contrast.
  • Elderly patients: monitor renal function and dosage closely due to increased susceptibility.
  • Store at ambient temperature: keep in original container, protect from moisture and heat.

Avoid Interactions

Metformin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Iodinated contrast agents: may precipitate acute renal failure; discontinue Metformin before imaging.
  • Cimetidine: can increase Metformin plasma concentrations, raising risk of toxicity.
  • Alcohol (excessive): potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask hypoglycaemia symptoms.
  • Diuretics (thiazides): can affect renal clearance of Metformin.
  • ACE inhibitors or ARBs: monitor renal function when combined.
  • Oral contraceptives: may modestly increase Metformin levels.
  • Rifampicin: may reduce Metformin exposure, requiring dose adjustment.

Frequently Asked Questions

Metformin Accord contains the active ingredient metformin, which is prescribed to lower high blood glucose levels in adults with type 2 diabetes mellitus. It helps improve glycaemic control by enhancing the body’s response to insulin and reducing glucose production by the liver.

Metformin works by activating AMP‑activated protein kinase (AMPK), a key regulator of cellular energy balance. This activation suppresses hepatic gluconeogenesis, reduces intestinal glucose absorption, and increases peripheral uptake of glucose, thereby lowering overall blood sugar without stimulating insulin release.

The appropriate dose of Metformin Accord is determined by the prescribing healthcare professional based on the individual’s medical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of metformin during pregnancy or lactation depends on clinical judgment. While some guidelines allow its use when benefits outweigh risks, the decision should be made by a qualified healthcare provider who can assess the specific circumstances of the mother and fetus or infant.

To request Metformin Accord, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin belongs to the biguanide class and is often first‑line therapy for type 2 diabetes because it does not cause weight gain and has a low risk of hypoglycaemia compared with sulfonylureas or insulin. It is frequently combined with other agents when additional glucose lowering is needed.

Metformin Accord should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, direct sunlight and excessive heat to maintain potency throughout its shelf life.

Metformin Accord is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets are swallowed whole with a glass of water. Patients should follow the dosing schedule prescribed by their healthcare professional.

The most serious potential risk is lactic acidosis, a rare but life‑threatening condition that can occur in patients with severe renal or hepatic impairment, or in those who consume excessive alcohol. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain or abdominal discomfort develop.

Metformin Accord is contraindicated in individuals with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in patients with known hypersensitivity to metformin or any component of the formulation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT